Medtech Insight caught up with Deltex Medical CEO Andy Mears during the Medica 2024 exhibition and conference in Düsseldorf, Germany, where the UK SME was profiling its TrueVue technology and taking the opportunity to meet international distributors for current and future business expansion.
Niche Innovator Deltex Medical On Market Access, EU MDR And A Mission To Change The World
TrueVue Oesophageal Doppler Monitor Developer Guards Its Space In A Market Characterized By Multinationals
The UK market has become tougher for smaller innovators, says Andy Mears, CEO of Deltex Medical, which plans to launch a new iteration of its minimally invasive ultrasound-based technology, the oesophageal Doppler monitor. He explained how market access challenges have steepened.
